体外毒物検査市場：製品（アッセイ（ウェスタンブロット、組織培養）、装置、消耗品、ソフトウェア）、毒性エンドポイント（ADME、皮膚刺激、細胞毒性）、技術、手法、産業（製薬、バイオテクノロジー）-2027年までの世界予測

In Vitro Toxicology Testing Market by Product (Assays (Western Blot, Tissue Culture), Equipment, Consumables, Software), Toxicity Endpoints (ADME, Skin Irritation, Cytotoxicity), Technology, Method, Industry (Pharma,Biotech) - Global Forecast to 2027

体外毒物検査市場は、2022年の推定112億米ドルから、2027年にはCAGR10.8％で186億米ドルに達すると予測されます。技術的な進歩や、医薬品開発の初期段階で毒性を検出するための研究開発費の増加などが、市場を牽... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2022年6月9日	US$4,950 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	356	376	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

体外毒物検査市場は、2022年の推定112億米ドルから、2027年にはCAGR10.8％で186億米ドルに達すると予測されます。技術的な進歩や、医薬品開発の初期段階で毒性を検出するための研究開発費の増加などが、市場を牽引する要因となっています。

"2021年にはADMEセグメントが最大の市場シェアを占めると予想される。"
in vitro毒性試験市場は、あらゆる産業で実施される毒性エンドポイントや試験に基づいて、遺伝毒性、細胞毒性、ADME、皮膚刺激・腐食・感作、眼毒性、器官毒性、光毒性、皮膚毒性、その他のエンドポイント＆試験に区分されます。2021年のin vitro毒性試験市場では、ADME分野が最大のシェアを占めています。

"予測期間中は、ソフトウェア分野が最も高い成長率を示すと予想される。"
製品およびサービスに基づいて、in vitro毒性試験市場は、消耗品、アッセイ、機器、ソフトウェア、およびサービスに区分されます。産業界におけるソフトウェア使用の増加により、ソフトウェア分野は予測期間中にin vitro toxicology testing市場で最も高い成長を見せると予測されます。

"予測期間中、トキシコゲノミクスは最も高い成長率を示すと予想される"
予測期間中、ゲノミクスとプロテオミクスの分野で起こっている技術的進歩により、トキシコゲノミクスセグメントは最も高いCAGRで成長すると予測されています。

"2021年、欧州はin vitro毒物検査市場で活動するプレーヤーにとって最大のシェアを占めると予想されます。"
2021年、欧州はin vitro毒物検査市場で最大のシェアを占めています。同地域の化学および化粧品産業におけるin vitro毒性試験アッセイおよびサービスの高い採用率などの要因が、同市場の成長に寄与すると予想される主な理由である。

本レポートで参照した主な参加企業の内訳は以下のとおりです。
- 企業タイプ別Tier 1 (35%)、Tier 2 (45%)、Tier 3 (20%)
- 役職別Cレベル(35%)、ディレクターレベル(25%)、その他(40%)
- 地域別北米（45％）、欧州（30％）、アジア太平洋（20％）、中南米（3％）、中近東・アフリカ（2）

インビト毒物検査市場の主要企業

インビトロ毒性試験市場の有力プレイヤーは、Thermo Fisher Scientific Inc.（米国）、Laboratory Corporation of America Holdings（米国）、Bio-Rad Laboratories, Inc.（米国）、General Electric Company（米国）、Eurofins Scientific（Luxembourg）、Merck KGaA（ドイツ）、Charles River Laboratories International, Inc.(米国）、Catalent, Inc.（米国）、Evotec（英国）、SGS S.A.（スイス）、QIAGEN（ドイツ）、Promega Corporation（米国）、Gentronix Limited（英国）、BioIVT（米国）、MB Research Laboratories（米国） ,Creative Biolabs（米国）, GVK Biosciences Private Limited（インド）, Shanghai Medicon Inc（中国）, Creative Biorray（米国）および Insphero（スイス）です。
調査対象
本レポートは、世界のin vitro毒性試験市場の市場規模および今後の成長可能性を、製品＆サービス、技術、毒性エンドポイント＆試験、産業、手法、地域セグメント別に推計することを目的としています。また、同市場の主要企業の詳細な競合分析、企業プロファイル、製品提供、最近の開発状況も掲載しています。
本レポートを購入する理由
本レポートは、既存企業だけでなく、新規参入企業や中小企業も市場の脈拍を測ることができ、ひいてはより大きなシェアを獲得するのに役立つことでしょう。本レポートを購入された企業は、以下の5つの戦略を組み合わせることで、市場での存在感を高めることができます。

本レポートでは、以下のポイントについて考察しています。
- 市場浸透。体外毒物検査の世界市場における上位企業が提供する製品ポートフォリオに関する包括的な情報
- 製品開発/イノベーション。体外毒物検査の世界市場における今後の動向、研究開発活動、製品発売に関する詳細な洞察
- 市場開発。有利な新興地域に関する包括的な情報
- 市場の多様化。新製品、成長地域、体外毒物検査の世界市場の最新動向に関する徹底的な情報提供
- 競争力のある評価。体外毒物検査の世界市場における主要企業の市場ランキング、成長戦略、収益分析、サービスに関する詳細な評価

ページTOPに戻る

1 INTRODUCTION 44
1.1 STUDY OBJECTIVES 44
1.2 MARKET DEFINITION 44
1.2.1 INCLUSIONS AND EXCLUSIONS 44
1.2.2 MARKETS COVERED 45
FIGURE 1 IN VITRO TOXICOLOGY TESTING MARKET 45
FIGURE 2 IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC SCOPE 46
1.2.3 YEARS CONSIDERED FOR STUDY 46
1.3 CURRENCY 47
1.4 STAKEHOLDERS 47
1.5 LIMITATIONS 47
1.6 SUMMARY OF CHANGES 47
2 RESEARCH METHODOLOGY 49
2.1 RESEARCH APPROACH 49
FIGURE 3 RESEARCH DESIGN 49
2.1.1 SECONDARY RESEARCH 49
2.1.1.1 Key data from secondary sources 50
2.1.2 PRIMARY RESEARCH 51
2.1.2.1 Key data from primary sources 51
2.1.2.2 Breakdown of primaries 52
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 52
2.2 MARKET SIZE ESTIMATION & VALIDATION APPROACH 52
FIGURE 5 MARKET SIZE APPROACH 54
FIGURE 6 BOTTOM-UP APPROACH 54
2.3 DATA TRIANGULATION APPROACH 55
FIGURE 7 DATA TRIANGULATION METHODOLOGY 55
2.4 MARKET SHARE ESTIMATION 56
2.5 ASSUMPTIONS FOR STUDY 56
3 EXECUTIVE SUMMARY 57
FIGURE 8 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE,
2022 VS. 2027 (USD MILLION) 57
FIGURE 9 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT &
TEST, 2022 VS. 2027 (USD MILLION) 58
FIGURE 10 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022 VS. 2027 (USD MILLION) 59
FIGURE 11 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022 VS. 2027 (USD MILLION) 59
FIGURE 12 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022 VS. 2027 (USD MILLION) 60
FIGURE 13 GEOGRAPHIC ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET 61
4 PREMIUM INSIGHTS 62
4.1 IN VITRO TOXICOLOGY TESTING MARKET OVERVIEW 62
FIGURE 14 OPPOSITION TO ANIMAL TESTING IS MAJOR FACTOR
DRIVING MARKET GROWTH 62
4.2 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD 63
FIGURE 15 CELLULAR ASSAYS HELD LARGEST SHARE OF IN VITRO TOXICOLOGY TESTING MARKET IN ASIA PACIFIC IN 2021 63
4.3 IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 64
FIGURE 16 CHINA IS LIKELY TO BE FASTEST-GROWING MARKET IN GLOBAL IN VITRO TOXICOLOGY TESTING MARKET DURING FORECAST PERIOD 64
4.4 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION 65
FIGURE 17 EUROPE WILL CONTINUE TO DOMINATE IN VITRO TOXICOLOGY TESTING MARKET IN 2027 65
4.5 IN VITRO TOXICOLOGY TESTING MARKET: DEVELOPED VS. DEVELOPING MARKETS 65
FIGURE 18 DEVELOPING MARKETS TO REGISTER HIGHER CAGR THAN DEVELOPED MARKETS THROUGHOUT FORECAST PERIOD 65
5 MARKET OVERVIEW 66
5.1 INTRODUCTION 66
5.2 MARKET DYNAMICS 66
FIGURE 19 IN VITRO TOXICOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 66
5.2.1 MARKET DRIVERS 67
5.2.1.1 Public opposition to animal testing 67
5.2.1.2 Technological advancements in toxicology 67
5.2.1.3 R&D on early-stage toxicity detection 68
5.2.2 MARKET RESTRAINTS 68
5.2.2.1 Reluctance of some regulatory authorities to adopt alternative toxicology testing methods 68
5.2.2.2 Failure to establish intricacies of in-vivo conditions 69
5.2.2.3 Lack of in vitro models to study complex endpoints 69
5.2.3 MARKET OPPORTUNITIES 69
5.2.3.1 Growing focus on drug discovery and personalized medicine using in vitro methods 69
5.2.3.2 Increasing number of toxicology databases 70
5.2.4 MARKET CHALLENGES 71
5.2.4.1 Dearth of skilled professionals in toxicity testing 71

6 INDUSTRY INSIGHTS 72
6.1 INTRODUCTION 72
6.2 INDUSTRY TRENDS 72
6.2.1 INCREASING FOCUS ON PREDICTIVE TOXICOLOGY 72
6.3 SUPPLY CHAIN ANALYSIS 73
FIGURE 20 SUPPLY CHAIN ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET 73
6.4 REGULATORY COMMITTEE ACTIVITIES 73
6.4.1 MAJOR STAKEHOLDERS 74
6.4.2 KEY INFLUENCERS 74
6.5 COVID-19 IMPACT ON IN VITRO TOXICOLOGY MARKET 75
FIGURE 21 IMPACT OF COVID-19 ON IN VITRO TOXICOLOGY TESTING MARKET 76
6.6 PORTER’S FIVE FORCES ANALYSIS 76
TABLE 1 PORTER’S FIVE FORCES ANALYSIS 76
6.6.1 THREAT OF NEW ENTRANTS 77
6.6.2 THREAT OF SUBSTITUTES 77
6.6.3 BARGAINING POWER OF SUPPLIERS 77
6.6.4 DEGREE OF COMPETITIVE RIVALRY 77
6.7 TECHNOLOGY ANALYSIS 77
7 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE 79
7.1 INTRODUCTION 80
7.2 COVID-19 IMPACT, BY PRODUCT & SERVICE 80
FIGURE 22 CONSUMABLES TO CAPTURE MAJORITY OF MARKET SHARE IN 2022 80
TABLE 2 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE,
2019–2021 (USD MILLION) 81
TABLE 3 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE,
2022–2027 (USD MILLION) 81
7.3 CONSUMABLES 82
7.3.1 CONSUMABLES TO ACCOUNT FOR LARGER MARKET SHARE THAN OTHER PRODUCTS IN 2022 82
TABLE 4 IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION) 83
TABLE 5 IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION) 84
7.4 ASSAYS 84
TABLE 6 ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY TYPE,
2019–2021 (USD MILLION) 85
TABLE 7 ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY TYPE,
2022–2027 (USD MILLION) 85
TABLE 8 ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY,
2019–2021 (USD MILLION) 86
TABLE 9 ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY,
2022–2027 (USD MILLION) 86
7.4.1 BACTERIAL TOXICITY ASSAYS 87
7.4.1.1 Bacterial assays to capture largest market share in coming years owing to their increasing adoption across several industries 87
TABLE 10 BACTERIAL TOXICITY ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2019–2021 (USD MILLION) 87
TABLE 11 BACTERIAL TOXICITY ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION) 88
7.4.2 ENZYME TOXICITY ASSAYS 88
7.4.2.1 Enzyme toxicity assays are increasingly used in endocrine-disrupting studies—major factor driving market growth 88
TABLE 12 ENZYME TOXICITY ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2019–2021 (USD MILLION) 89
TABLE 13 ENZYME TOXICITY ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION) 89
7.4.3 CELL-BASED ELISA & WESTERN BLOTS 90
7.4.3.1 Cell-based assays are cost-effective, thereby witnessing increasing adoption in drug discovery 90
TABLE 14 CELL-BASED ELISA & WESTERN BLOTS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION) 91
TABLE 15 CELL-BASED ELISA & WESTERN BLOTS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION) 91
7.4.4 RECEPTOR-BINDING ASSAYS 92
7.4.4.1 Receptor-binding assays are suitable for high-throughput formats, thereby exhibiting accelerated demand 92
TABLE 16 RECEPTOR-BINDING ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2019–2021 (USD MILLION) 92
TABLE 17 RECEPTOR-BINDING ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION) 93
7.4.5 TISSUE CULTURE ASSAYS 93
7.4.5.1 Tissue culture assays can mimic in-vivo tissue architecture, thereby attracting researchers 93
TABLE 18 TISSUE CULTURE ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2019–2021 (USD MILLION) 94
TABLE 19 TISSUE CULTURE ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION) 94
7.4.6 OTHER ASSAYS 95
TABLE 20 OTHER ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION) 95
TABLE 21 OTHER ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION) 96
7.5 EQUIPMENT 96
7.5.1 FULLY AUTOMATED IN VITRO TOXICOLOGY EQUIPMENT ARE INCREASINGLY ADOPTED IN RESEARCH 96
TABLE 22 EQUIPMENT: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION) 97
TABLE 23 EQUIPMENT: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION) 98

7.6 SOFTWARE 98
7.6.1 SOFTWARE SOLUTIONS ARE VITAL IN REDUCING ANALYSIS TIME AND MANAGING LARGE VOLUMES OF DATA GENERATED DURING OPERATIONS 98
TABLE 24 SOFTWARE: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY,
2019–2021 (USD MILLION) 99
TABLE 25 SOFTWARE: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY,
2022–2027 (USD MILLION) 100
7.7 SERVICES 100
7.7.1 LACK OF INFRASTRUCTURE AND EXPERTISE HAVE DRIVEN RELIANCE ON SERVICE PROVIDERS 100
TABLE 26 SERVICES: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY,
2019–2021 (USD MILLION) 101
TABLE 27 SERVICES: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY,
2022–2027 (USD MILLION) 102
8 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST 103
8.1 INTRODUCTION 104
FIGURE 23 ORGAN TOXICITY TESTING TO REGISTER HIGHEST
CAGR DURING FORECAST PERIOD 104
TABLE 28 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT &
TEST, 2019–2021 (USD MILLION) 105
TABLE 29 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT &
TEST, 2022–2027 (USD MILLION) 105
8.2 ADME (ABSORPTION, DISTRIBUTION, METABOLISM, & EXCRETION) 106
8.2.1 ADME TESTING TO COMMAND IN VITRO TOXICOLOGY TESTING MARKET DURING FORECAST PERIOD 106
TABLE 30 ADME: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY,
2019–2021 (USD MILLION) 107
TABLE 31 ADME: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY,
2022–2027 (USD MILLION) 107
8.3 SKIN IRRITATION, CORROSION, & SENSITIZATION 108
8.3.1 SKIN IRRITATION, CORROSION, & SENSITIZATION ARE MAJOR ENDPOINTS STUDIED IN COSMETICS INDUSTRY 108
TABLE 32 SKIN IRRITATION, CORROSION, & SENSITIZATION: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION) 109
TABLE 33 SKIN IRRITATION, CORROSION, & SENSITIZATION: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION) 109
8.4 GENOTOXICITY 110
8.4.1 REGULATORY AUTHORITIES REVIEW AND VALIDATE HIGHER NUMBER OF GENOTOXICITY TESTS THAN ANY OTHER ENDPOINT, THEREBY PROPELLING MARKET GROWTH 110
TABLE 34 GENOTOXICITY: IN VITRO TOXICOLOGY TESTING, BY GEOGRAPHY,
2019–2021 (USD MILLION) 111
TABLE 35 GENOTOXICITY: IN VITRO TOXICOLOGY TESTING, BY GEOGRAPHY,
2022–2027 (USD MILLION) 111
8.5 CYTOTOXICITY 112
8.5.1 RISING NEED FOR BIOSAFETY LARGELY CONTRIBUTES TO GROWTH OF CYTOTOXICITY TESTING MARKET 112
TABLE 36 CYTOTOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION) 113
TABLE 37 CYTOTOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION) 113
8.6 OCULAR TOXICITY TESTING 114
8.6.1 IN VITRO AND EX-VIVO METHODS ARE GAINING HIGH RECOGNITION FOR OCULAR TOXICITY TESTING 114
TABLE 38 OCULAR TOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION) 114
TABLE 39 OCULAR TOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION) 115
8.7 ORGAN TOXICITY 115
8.7.1 HIGH-CONTENT SCREENING AND CELL-BASED ASSAYS ARE USED TO DETECT ORGAN-SPECIFIC TOXICITY 115
TABLE 40 ORGAN TOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION) 116
TABLE 41 ORGAN TOXICITY: TE IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION) 117
8.8 PHOTOTOXICITY 117
8.8.1 VALIDATED NON-ANIMAL METHODS ARE USED TO EVALUATE PHOTO SAFETY OF COSMETICS, PHARMACEUTICALS, & CHEMICALS 117
TABLE 42 PHOTOTOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION) 118
TABLE 43 PHOTOTOXICITY: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION) 119
8.9 DERMAL TOXICITY 119
8.9.1 IN VITRO METHODS FOR DERMAL TOXICITY TESTING ARE EXPECTED TO GAIN RECOGNITION IN COMING YEARS 119
TABLE 44 DERMAL TOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION) 120
TABLE 45 DERMAL TOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION) 121
8.10 OTHER ENDPOINTS & TESTS 121
TABLE 46 OTHER ENDPOINTS & TESTS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2019–2021 (USD MILLION) 122
TABLE 47 OTHER ENDPOINTS & TESTS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION) 122
9 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY 123
9.1 INTRODUCTION 124
FIGURE 24 TOXICOGENOMICS SEGMENT TO EXHIBIT HIGHEST CAGR IN IN VITRO TOXICOLOGY TESTING MARKET DURING FORECAST PERIOD 124
TABLE 48 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2019–2021 (USD MILLION) 124
TABLE 49 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022–2027 (USD MILLION) 125

9.2 CELL CULTURE 125
9.2.1 CELL- & TISSUE-BASED TECHNOLOGIES ARE WIDELY ADOPTED
IN IN VITRO TESTING 125
TABLE 50 CELL CULTURE: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION) 126
TABLE 51 CELL CULTURE: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION) 126
9.3 HIGH-THROUGHPUT 127
9.3.1 INCREASING USE OF HIGH-CONTENT IMAGING TECHNOLOGIES IN TOXICITY TESTING BOOSTS MARKET GROWTH 127
TABLE 52 HIGH-THROUGHPUT: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2019–2021 (USD MILLION) 128
TABLE 53 HIGH-THROUGHPUT: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION) 128
9.4 TOXICOGENOMICS 129
9.4.1 IMPROVEMENTS IN PROTEOMIC TECHNOLOGIES ENHANCE STUDY OF GENES & PROTEIN ACTIVITIES DURING TOXICITY ANALYSIS 129
TABLE 54 TOXICOGENOMICS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION) 129
TABLE 55 TOXICOGENOMICS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION) 130
10 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY 131
10.1 INTRODUCTION 132
FIGURE 25 PHARMACEUTICALS & BIOPHARMACEUTICALS INDUSTRY TO HOLD LARGEST MARKET SHARE THROUGHOUT FORECAST PERIOD 132
TABLE 56 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2019–2021 (USD MILLION) 132
TABLE 57 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022–2027 (USD MILLION) 133
10.2 COVID-19 IMPACT, BY INDUSTRY 133
10.3 PHARMACEUTICALS & BIOPHARMACEUTICALS 133
10.3.1 DRUG ATTRITION RATE LEADS TO HIGH ADOPTION OF IN VITRO TESTING ASSAYS IN EARLY STAGES OF DRUG DEVELOPMENT 133
TABLE 58 PHARMACEUTICALS & BIOPHARMACEUTICALS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION) 135
TABLE 59 PHARMACEUTICALS & BIOPHARMACEUTICALS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION) 136
10.4 COSMETICS & HOUSEHOLD PRODUCTS 136
10.4.1 BAN ON ANIMAL TESTING LEADING TO ADOPTION OF IN VITRO ASSAYS FOR SAFETY TESTING 136
TABLE 60 COSMETICS & HOUSEHOLD PRODUCTS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION) 137
TABLE 61 COSMETICS & HOUSEHOLD PRODUCTS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION) 138
10.5 FOOD 138
10.5.1 INCREASING FOCUS ON FOOD SAFETY DRIVES REQUIREMENT FOR IN VITRO TOXICOLOGY TESTING PRODUCTS 138
TABLE 62 TYPES OF TOXICOLOGY TESTS IN FOOD 139
TABLE 63 FOOD: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY,
2019–2021 (USD MILLION) 140
TABLE 64 FOOD: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY,
2022–2027 (USD MILLION) 141
10.6 CHEMICALS 141
10.6.1 INCREASING FOCUS ON ORGANOID-BASED IN VITRO APPROACHES FOR CHEMICALS TESTING PROPELS MARKET GROWTH 141
TABLE 65 CHEMICALS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION) 142
TABLE 66 CHEMICALS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION) 143
11 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD 144
11.1 INTRODUCTION 145
FIGURE 26 IN-SILICO MODELS TO RECORD HIGHEST CAGR IN IN VITRO TOXICOLOGY TESTING MARKET DURING FORECAST PERIOD 145
TABLE 67 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019–2021 (USD MILLION) 145
TABLE 68 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022–2027 (USD MILLION) 146
11.2 CELLULAR ASSAYS 146
11.2.1 DEVELOPMENT OF MULTI-PARAMETER ASSAYS WILL PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES TO MARKET PLAYERS 146
TABLE 69 CELLULAR ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2019–2021 (USD MILLION) 147
TABLE 70 CELLULAR ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION) 148
11.3 BIOCHEMICAL ASSAYS 148
11.3.1 BIOCHEMICAL ASSAYS ARE ADOPTED AT HIGHER RATE IN PHARMACEUTICALS INDUSTRY THAN CHEMICALS AND FOOD INDUSTRIES 148
TABLE 71 BIOCHEMICAL ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2019–2021 (USD MILLION) 149
TABLE 72 BIOCHEMICAL ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION) 150
11.4 IN-SILICO MODELS 150
11.4.1 IN-SILICO MODELS ARE EXPECTED TO WITNESS HIGHEST CAGR
FROM 2022 TO 2027 150
TABLE 73 IN-SILICO MODELS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2019–2021 (USD MILLION) 151
TABLE 74 IN-SILICO MODELS: IN VITRO TOXICOLOGY TESTING MARKET,
BY GEOGRAPHY, 2022–2027 (USD MILLION) 152
11.5 EX-VIVO MODELS 152
11.5.1 EX-VIVO MODELS ARE WIDELY USED IN SKIN AND EYE TOXICOLOGY TESTING IN COSMETICS INDUSTRY 152
TABLE 75 EX-VIVO MODELS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION) 153
TABLE 76 EX-VIVO MODELS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION) 154
12 IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHIC ANALYSIS 155
12.1 INTRODUCTION 156
12.2 COVID-19 IMPACT, BY REGION 156
FIGURE 27 IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC SNAPSHOT 157
TABLE 77 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION,
2019–2021 (USD MILLION) 157
TABLE 78 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION,
2022–2027 (USD MILLION) 158
12.3 EUROPE 158
FIGURE 28 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT 159
TABLE 79 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY,
2019–2021 (USD MILLION) 160
TABLE 80 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY,
2022–2027 (USD MILLION) 160
TABLE 81 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION) 161
TABLE 82 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION) 161
TABLE 83 EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2019–2021 (USD MILLION) 162
TABLE 84 EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2022–2027 (USD MILLION) 162
TABLE 85 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION) 163
TABLE 86 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION) 163
TABLE 87 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2019–2021 (USD MILLION) 164
TABLE 88 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022–2027 (USD MILLION) 164
TABLE 89 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2019–2021 (USD MILLION) 164
TABLE 90 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022–2027 (USD MILLION) 165
TABLE 91 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019–2021 (USD MILLION) 165
TABLE 92 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022–2027 (USD MILLION) 165
12.3.1 GERMANY 166
12.3.1.1 Germany holds the largest share of the European market 166
TABLE 93 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION) 167
TABLE 94 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION) 167
TABLE 95 GERMANY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2019–2021 (USD MILLION) 168
TABLE 96 GERMANY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2022–2027 (USD MILLION) 168
TABLE 97 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION) 169
TABLE 98 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION) 169
TABLE 99 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2019–2021 (USD MILLION) 170
TABLE 100 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022–2027 (USD MILLION) 170
TABLE 101 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2019–2021 (USD MILLION) 170
TABLE 102 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022–2027 (USD MILLION) 171
TABLE 103 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019–2021 (USD MILLION) 171
TABLE 104 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022–2027 (USD MILLION) 171
12.3.2 UK 172
12.3.2.1 Rising awareness, growing R&D, and increasing collaborations
for In Vitro Toxicology Testing Market are key indicators of market growth in UK 172
TABLE 105 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION) 173
TABLE 106 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION) 173
TABLE 107 UK: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2019–2021 (USD MILLION) 174
TABLE 108 UK: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2022-2027 (USD MILLION) 174
TABLE 109 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION) 175
TABLE 110 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION) 175
TABLE 111 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2019–2021 (USD MILLION) 176
TABLE 112 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022–2027 (USD MILLION) 176
TABLE 113 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2019–2021 (USD MILLION) 176
TABLE 114 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022–2027 (USD MILLION) 177
TABLE 115 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019–2021 (USD MILLION) 177
TABLE 116 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022–2027 (USD MILLION) 177
12.3.3 FRANCE 178
12.3.3.1 Proteomics research initiatives supported by government aid market growth in France 178
TABLE 117 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION) 179
TABLE 118 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION) 179
TABLE 119 FRANCE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2019–2021 (USD MILLION) 180
TABLE 120 FRANCE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2022–2027 (USD MILLION) 180
TABLE 121 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION) 181
TABLE 122 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION) 181
TABLE 123 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2019–2021 (USD MILLION) 182
TABLE 124 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022–2027 (USD MILLION) 182
TABLE 125 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2019–2021 (USD MILLION) 182
TABLE 126 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022–2027 (USD MILLION) 183
TABLE 127 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019–2021 (USD MILLION) 183
TABLE 128 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022–2027 (USD MILLION) 183
12.3.4 ITALY 184
12.3.4.1 Italian market growth is mainly driven by increased volume of life sciences research 184
TABLE 129 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION) 184
TABLE 130 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION) 185
TABLE 131 ITALY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2019–2021 (USD MILLION) 185
TABLE 132 ITALY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2022–2027 (USD MILLION) 186
TABLE 133 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION) 186
TABLE 134 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION) 187
TABLE 135 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2019–2021 (USD MILLION) 187
TABLE 136 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022–2027 (USD MILLION) 188
TABLE 137 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2019–2021 (USD MILLION) 188
TABLE 138 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022–2027 (USD MILLION) 188
TABLE 139 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019–2021 (USD MILLION) 189
TABLE 140 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022–2027 (USD MILLION) 189
12.3.5 SPAIN 189
12.3.5.1 Spain’s growing Chemicals industry stimulates in vitro toxicology testing market growth 189
TABLE 141 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION) 190
TABLE 142 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION) 190
TABLE 143 SPAIN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2019–2021 (USD MILLION) 191
TABLE 144 SPAIN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2022–2027 (USD MILLION) 191
TABLE 145 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION) 192
TABLE 146 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION) 192
TABLE 147 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2019–2021 (USD MILLION) 193
TABLE 148 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022–2027 (USD MILLION) 193
TABLE 149 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2019–2021 (USD MILLION) 193
TABLE 150 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022–2027 (USD MILLION) 194
TABLE 151 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019–2021 (USD MILLION) 194
TABLE 152 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022–2027 (USD MILLION) 194
12.3.6 REST OF EUROPE 195
TABLE 153 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION) 196
TABLE 154 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION) 196
TABLE 155 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019–2021 (USD MILLION) 196
TABLE 156 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022–2027 (USD MILLION) 197
TABLE 157 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION) 197
TABLE 158 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION) 198
TABLE 159 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019–2021 (USD MILLION) 198
TABLE 160 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2022–2027 (USD MILLION) 199
TABLE 161 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019–2021 (USD MILLION) 199
TABLE 162 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2022–2027 (USD MILLION) 199
TABLE 163 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019–2021 (USD MILLION) 200
TABLE 164 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2022–2027 (USD MILLION) 200
12.4 NORTH AMERICA 201
FIGURE 29 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT 202
TABLE 165 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2019–2021 (USD MILLION) 202
TABLE 166 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2022–2027 (USD MILLION) 203
TABLE 167 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION) 203
TABLE 168 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION) 203
TABLE 169 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019–2021 (USD MILLION) 204
TABLE 170 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022–2027 (USD MILLION) 204
TABLE 171 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION) 205
TABLE 172 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION) 205
TABLE 173 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019–2021 (USD MILLION) 206
TABLE 174 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2022–2027 (USD MILLION) 206
TABLE 175 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019–2021 (USD MILLION) 206
TABLE 176 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2022–2027 (USD MILLION) 207
TABLE 177 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019–2021 (USD MILLION) 207
TABLE 178 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2022–2027 (USD MILLION) 207
12.4.1 US 208
12.4.1.1 US dominates North American market due to growing focus on biomarker discovery and research in structure-based drug design 208
TABLE 179 US: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION) 209
TABLE 180 US: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION) 209
TABLE 181 US: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2019–2021 (USD MILLION) 210
TABLE 182 US: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2022–2027 (USD MILLION) 210
TABLE 183 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION) 211
TABLE 184 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION) 211
TABLE 185 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2019–2021 (USD MILLION) 212
TABLE 186 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022–2027 (USD MILLION) 212
TABLE 187 US: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2019–2021 (USD MILLION) 212
TABLE 188 US: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022–2027 (USD MILLION) 213
TABLE 189 US: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019–2021 (USD MILLION) 213
TABLE 190 US: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022–2027 (USD MILLION) 213
12.4.2 CANADA 214
12.4.2.1 Strong support to carry out R&D in pharmaceutical and proteomics fields fosters market growth in Canada 214
TABLE 191 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION) 215
TABLE 192 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION) 215
TABLE 193 CANADA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2019–2021 (USD MILLION) 216
TABLE 194 CANADA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2022–2027 (USD MILLION) 216
TABLE 195 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION) 217
TABLE 196 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION) 217
TABLE 197 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2019–2021 (USD MILLION) 218
TABLE 198 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2022–2027 (USD MILLION) 218
TABLE 199 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2019–2021 (USD MILLION) 218
TABLE 200 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2022–2027 (USD MILLION) 219
TABLE 201 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019–2021 (USD MILLION) 219
TABLE 202 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2022–2027 (USD MILLION) 219

ページTOPに戻る

Table of Contents

Summary

The in vitro toxicology testing market is expected to reach USD 18.6 billion by 2027 from an estimated USD 11.2 billion in 2022, at a CAGR of 10.8%. Factors such as, technological advancements, and increasing R&D expenditure to detect toxicity at an early stage during drug development are the factors to drive the market

“The ADME segment is expected to account for the largest market share in 2021.”
Based on toxicity endpoints and tests undertaken across all industries, the in vitro toxicity testing market is segmented into genotoxicity; cytotoxicity; ADME; skin irritation, corrosion, & sensitization; ocular toxicity; organ toxicity; phototoxicity; dermal toxicity; and other endpoints & tests. In 2021, the ADME segment accounted for the largest share of the in vitro toxicity testing market.

“During the forecast period, the software segment is expected to grow at the highest rate.”
On the basis of product and service, the in vitro toxicology testing market is segmented into consumables, assays, equipment, software, and services. Due to the increasing use of softwares in industry, the software segment is projected to witness the highest growth in the in vitro toxicology testing market during the forecast period.

“During the forecast period, toxicogenomics is expected to grow at the highest rate.”
During the forecast period, the toxicogenomics segment is expected to grow at the highest CAGR, due to the technological advancements taking place in the field of genomics and proteomics.

“In 2021, Europe is expected to hold the largest share for players operating in the in vitro toxicology testing market.”
In 2021, Europe accounted for the largest share of the in vitro toxicology testing market. Factors such as high adoption of in vitro toxicology testing assays and services in the chemical and cosmetics industries in the region are among the primary reasons expected to contribute to the growth of this market.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1 (35%), Tier 2 (45%), and Tier 3 (20%)
• By Designation: C-level (35%), Director-level (25%), and Others (40%)
• By Region: North America (45%), Europe (30%), Asia Pacific (20%), Latin America (3%), and the Middle East & Africa (2%)

Key players in the In Vito Toxiocology Testing Market

The prominent players in the in vitro toxicology testing market include Thermo Fisher Scientific Inc. (US), Laboratory Corporation of America Holdings (US), Bio-Rad Laboratories, Inc. (US), General Electric Company (US), Eurofins Scientific (Luxembourg), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Catalent, Inc. (US), Evotec (UK), SGS S.A. (Switzerland), QIAGEN (Germany), Promega Corporation (US), Gentronix Limited (UK), BioIVT (US), MB Research Laboratories (US) ,Creative Biolabs(US), GVK Biosciences Private Limited (India), Shanghai Medicon Inc (China), Creative Biorray (US) and Insphero (Switzerland).
Research Coverage:
The report aims at estimating the market size and future growth potential of the global in vitro toxicology testing market and its product & service, technology, toxicity endpoint & test, industry, method, and regional segments. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global in vitro toxicology testing market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the global in vitro toxicology testing market
• Market Development: Comprehensive information on the lucrative emerging regions
• Market Diversification: Exhaustive information about the new product, growing geographies, and recent developments in the global in vitro toxicology testing market
• Competitive Assessment: In-depth assessment of market ranking, growth strategies, revenue analysis, and services of leading players in the global in vitro toxicology testing market

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（その他（治療を主目的としない薬物））の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（adme）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（その他（治療を主目的としない薬物））の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（adme）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?